Controlling gene expression in cells using light and magnetic fields
Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function
['FUNDING_R01'] · CENTRAL MICHIGAN UNIVERSITY · NIH-10277517
This study is working on a new way to control how genes work in cells using light and electromagnetic fields, which could help improve treatments for different diseases by allowing doctors to target specific genes without disrupting the cell's normal functions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CENTRAL MICHIGAN UNIVERSITY (nih funded) |
| Locations | 1 site (MOUNT PLEASANT, UNITED STATES) |
| Trial ID | NIH-10277517 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new tool that allows for precise control of gene expression within cells using electromagnetic fields and light. By creating a synthetic biological system, researchers aim to manipulate cellular functions remotely, which could lead to advancements in therapeutic applications. The approach involves designing biomagnetic switches that convert electromagnetic energy into biological actions, enabling targeted gene activation without interfering with existing cellular processes. This innovative method could revolutionize how we understand and treat various diseases at the cellular level.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions that could benefit from targeted gene therapies or those involved in studies of cellular function.
Not a fit: Patients with conditions that do not involve cellular dysfunction or gene expression issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that allow for precise control of cellular functions, improving treatment options for various diseases.
How similar studies have performed: While the approach of using electromagnetic fields for gene control is innovative, similar techniques in synthetic biology have shown promise in other contexts, suggesting potential for success.
Where this research is happening
MOUNT PLEASANT, UNITED STATES
- CENTRAL MICHIGAN UNIVERSITY — MOUNT PLEASANT, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HOCHGESCHWENDER, UTE H — CENTRAL MICHIGAN UNIVERSITY
- Study coordinator: HOCHGESCHWENDER, UTE H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Disease